Conor McNamara
Stock Analyst at RBC Capital
(1.33)
# 3,658
Out of 5,115 analysts
141
Total ratings
35.92%
Success rate
-10.47%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $59.19 | +23.33% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.30 | +51.52% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $235.54 | +8.26% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.97 | +52.67% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $101.54 | -54.70% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $74.50 | +16.78% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $11.28 | +50.71% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $135.32 | -6.89% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $301.75 | +35.54% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $300.03 | +36.32% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $166.13 | +22.80% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $579.12 | +9.99% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $231.47 | +8.01% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.98 | +110.49% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.51 | +55.21% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $59.19
Upside: +23.33%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.30
Upside: +51.52%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $235.54
Upside: +8.26%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.97
Upside: +52.67%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $101.54
Upside: -54.70%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $74.50
Upside: +16.78%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.28
Upside: +50.71%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $135.32
Upside: -6.89%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $301.75
Upside: +35.54%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $300.03
Upside: +36.32%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $166.13
Upside: +22.80%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $579.12
Upside: +9.99%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $231.47
Upside: +8.01%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.98
Upside: +110.49%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.51
Upside: +55.21%